Background and Aims: Recently, smooth muscle hypertrophy has been suggested to be a contributor to small bowel lesions secondary to Crohn's disease [CD], in addition to inflammation and fibrosis. Here, we assess the value of magnetic resonance imaging [MRI] for the characterisation of histopathological tissue composition of small bowel CD, including inflammation, fibrosis, and smooth muscle hypertrophy. 
Introduction
Crohn's disease [CD] is a chronic inflammatory bowel disease that can involve any location within the gastrointestinal tract but most frequently the distal small bowel [terminal ileum]. 1 It is characterised by transmural inflammation with remitting and relapsing episodes. Pathologically, involvement by CD is manifested by inflammation and fibrosis which may co-exist in stenotic lesions. 2, 3 Assessment of bowel tissue composition in patients with CD, including the degree of inflammatory activity and fibrosis content particularly in stenotic lesions, is extremely important for directing appropriate management, as surgery may be the only option in cases of prominent fibrosis. 4 Several pathology studies have reported that smooth muscle hypertrophy is a contributor to strictures in CD, sometimes described to be more predominant than fibrosis. [5] [6] [7] [8] [9] [10] It is noteworthy that in some studies, the presence of smooth muscle hypertrophy was included in the histopathological fibrosis score in CD. 11, 12 Imaging plays an important role at initial diagnosis, for assessing response to therapy, and for diagnosing complications in CD. [13] [14] [15] Diffusion-weighted imaging [DWI] is a magnetic resonance imaging [MRI] technique that quantifies the degree of Brownian water motion in tissues. 16 It is established that highly cellular tissues such as neoplasms or inflammation/infection demonstrate restricted diffusion. 16 The apparent diffusion coefficient [ADC] computed from DWI decreases in tissues with restricted diffusion such as in active inflammatory bowel disease. [17] [18] [19] [20] There are a limited number of single-centre studies that have compared CT 11 or MRI with/without DWI with/without FDG-PET with surgical pathological findings in CD. 12, [21] [22] [23] [24] [25] [26] [27] Wall thickness, pattern of enhancement [layered] and T2 signal intensity have been described as sensitive to inflammation. 21, 23, 24, 27 The degree of wall enhancement has variable performance depending on the post-contrast phases and the studies. 21, 23, 24 The assessment of bowel wall fibrosis with MRI seems to be less accurate. Zappa et al. showed that wall thickness and hyperintensity on T2-weighted imaging [T2WI], as well as the presence of fistulous disease, are correlated with histopathological fibrosis score. 23 More recently, Rimola et al. showed that MRI is accurate for detecting the presence of severe fibrosis in CD lesions on the basis of delayed pattern of enhancement, 12 and Catalano et al. showed that ADC is not useful in detecting bowel wall fibrosis. 25 To our knowledge, there are no published data correlating MRI with small bowel smooth muscle hypertrophy in CD.
The objective of our study was to assess the value of MRI including DWI for the characterisation of histopathological tissue composition of small bowel CD, particularly including smooth muscle hypertrophy, as well as inflammation and fibrosis.
Methods
This retrospective Health Insurance Portability and Accountability Act [HIPAA]-compliant study was approved by our Institutional Review Board, and informed consent was waived.
Patients
A computerised search of our imaging database from March 2013 to October 2014 was conducted by the study coordinator, an abdominal radiologist with 5 years of experience in body MRI [MW] , to identify patients who underwent MRI and surgery. Our inclusion criteria were: patients with CD involving the small bowel [proved by endoscopy and histological analysis at the time of the diagnosis], who underwent small bowel resection, with pre-surgical MRI including DWI within 1 month before surgery. The flowchart of the study is presented in Fig. 1 
MRI technique
Patients were asked to fast for 6 h before the examination. The MRI examinations were performed using clinical 1.5 or 3T systems [Avanto/Aera/Skyra, Siemens Healthineers, Germany; Optima/ Discovery, General Electrics]. Thirty patients [86%] were imaged at 1.5T and five patients at 3.0T [14%]. To achieve adequate small bowel distension, three bottles of Volumen [EZ-E-M, Westbury, NY] were given orally, beginning 45 min before the MRI, and one bottle of water was given once the patient was in the scanner. To reduce bowel peristalsis, 1 mg of glucagon was administered intramuscularly before the beginning of the examination [except in diabetic patients].
For all sequences, we used parallel imaging factor 2 with a rectangular field of view of 300 x 400 mm, which was adjusted for patient's body size. The protocol [ For MaRIA score computation, the wall thickness was measured on post-contrast T1W images. For oedema and ulceration, the score was multiplied by 1 in case of presence, and by 0 in case of absence, as described by Rimola et al. 27 
Histopathological analysis
Histopathological analysis was performed retrospectively by a specialised gastrointestinal pathologist [HMK], on resected small bowel specimens. For each resection specimen, one section from the area of the ileum most involved by CD was selected. The most involved section was either derived from the pathology report, as a slide corresponding to the area designated as 'stricture', or an area of the bowel that appeared most thickened on examination of the slides. Sections involving fistulas were avoided, due to mural distortion by abscess component. Active inflammation was assessed on haematoxylin and eosin staining [H&E] slides using a 3-point scale, based on the depth of neutrophil infiltrates: 1, none or in mucosa only; 2, submucosa; and 3, muscularis propria/subserosa/serosa. Bowel wall oedema [fluid within the interstitial spaces of the tissue] was assessed using a 2-point scale: 1, no oedema or minimal oedema; and 2, obvious oedema. Active inflammation and wall oedema were assessed separately because they are not always associated.
Immunostaining of smooth muscle actin [SMA] for muscular hypertrophy and Sirius red special staining for collagen deposition were performed. 28, 29 Sirius red was chosen over Masson trichrome, because it has been shown that Sirius red is more specific and reliable for collagen staining than Masson trichrome. 30 Stained slides were digitally scanned and analysed using HALO morphometry software [v1.1, Indica Labs] by another pathologist [XZ] . Intramural areas of muscle and collagen were calculated for each affected full-thickness area. The area was normalised by dividing by the length of the section (mean of inner and outer measurements in each layer of wall [normalizsd SMA and normalized Sirius red]). The ratio between normalised SMA and normalised Sirius red was calculated [ratio <1: disproportionately increased fibrosis; ratio > 1: disproportionately increased muscular hypertrophy].
Imaging-pathology correlation
The study coordinator collected all the data and was responsible for the correlation between MRI and pathological findings. Pathological analysis was matched with MR images, based on surgical and pathology reports and MRI analysis, to ensure that the same bowel segments were analysed in case of patients with multifocal bowel involvement, according to location and length of involvement.
Statistical analysis
Quantitative variables are described as mean ± standard deviation [SD] . Qualitative variables are described as number of cases [percentage of cases]. MRI parameters were compared between affected and non-affected bowel segments stratified by histopathological inflammation score, edema score, and the ratio between normalised SMA and normalised Sirius red, using the chi square or the Fisher exact test for qualitative variables and the Mann-Whitney test for quantitative variables. Logistic regression univariate and multivariate analyses were also performed to compare the ability of MRI parameters, to predict inflammation/oedema and fibrosis/muscular hypertrophy. Linear regression analysis was performed between quantitative MRI parameters and histopathological scores. For significant quantitative parameters, a receiver operating characteristic curve analysis [ROC] was also performed. The tests were always two-sided, with a level of significance set at p <0.05. All analyses were performed using SPSS software [version 17.0, SPSS Inc., Chicago, IL]. ADC was significantly lower, and wall thickness on T1W postcontrast imaging and MaRIA score were both significantly higher, in inflammation grades 2/3 compared with grade 1. On multivariate regression analysis, including all the significant parameters in univariate analysis [except MaRIA score which is not independent from the others], only the degree of enhancement was associated with inflammation.
Results

Histopathological findings
MRI findings according to the degree of oedema
Significantly more ulcerations were found in segments with oedema; and MaRIA/Clermont scores were significantly higher in segments with oedema [ Tables 4 and 5 ].
MRI findings according to the degree of muscular hypertrophy and fibrosis
Bowel wall thickness on T2WI was significantly increased in bowel segments with prominent muscle hypertrophy compared with those with prominent fibrosis, whereas there was only a trend to increased bowel wall thickness on T1W post-contrast images. There was no difference in pattern of enhancement, degree of enhancement, and ADC between segments with prominent muscle hypertrophy versus those with prominent fibrosis, whereas there was a trend towards higher MaRIA and Clermont scores in bowel segments with prominent muscle hypertrophy. Bowel wall thickness on T2WI, T1WI, and MaRia and Clermont scores was significantly associated with the ratio between muscle hypertrophy and fibrosis [Tables 6-8, Figs 2 and 3] . The presence of fistulas was also significantly and independently associated with prominent muscle hypertrophy [OR = 14.5; p = 0.017]. ADC was significantly negatively correlated with normalised SMA, and wall thickness on T1WI and MaRIA and Clermont scores was significantly positively correlated with normalised SMA [ 
Area under receiver operating characteristic curve analysis
For detection of inflammation grades 2/3 and grade 1, length of involved bowel, wall thickness on T1w post-contrast imaging, ADC and MaRIA score had significant areas under receiver operating characteristic curves [AUROC] . The association of an ADC lower than 1.11 x 10 -3 mm 2 /s and a MaRIA score higher than 26.1 reached sensitivity of 47% and a specificity of 92% for detecting inflammation grades 2/3; and the association of an ADC lower than 1.11 x 10 -3 mm 2 /s and a wall thickness on T1w post-contrast higher than 5.9 mm reached a sensitivity of 65% and a specificity of 83% for detecting inflammation grades 2/3. For identification of oedema, both MaRIA and Clermont scores had significant AUROC. For differentiation of wall with prominent fibrosis and muscular hypertrophy, only the wall thickness measured on T2WI had a significant AUC [ Table 9 ].
Discussion
Our results showed that MRI can predict histopathological composition of ileal CD, including inflammation/oedema and disproportionately increased muscular hypertrophy over fibrosis, with reasonable diagnostic performance. On pathology, stenotic lesions in CD are histopathologically characterised by reduced bowel lumen and thickened bowel wall secondary to fibromuscular hypertrophy, with possible concomitant inflammation. Several pathological studies have reported that smooth muscle hypertrophy contributes to stricture formation, particularly within the muscularis mucosae. [5] [6] [7] [8] [9] [10] Because of the great variation of the relative composition of different components, CD lesions are highly heterogeneous both radiologically and histopathologically. Our results show that MRI can be useful in estimating the relative composition of the three most important components in ileal CD lesions, including inflammation/ oedema, smooth muscle hypertrophy, and fibrosis.
Compared with computed tomography, CT, MRI has the advantage of lack of radiation exposure, higher soft-tissue contrast, and additional information relating to diffusion, enhancement/perfusion, and peristalsis.
14 Consequently, MRI plays an important role in CD and is becoming the first-line imaging method for CD evaluation. [13] [14] [15] MRI is used in CD at every step of patient management: initial assessment for activity, extent of disease, diagnosis of complications [fistulas, abscesses], and follow-up after therapy. 13, 14, 31, 32 There are a limited number of studies that have compared MRI with/ without DWI with surgical pathological findings in CD. 12, [21] [22] [23] [24] 26 Even though used in many centres, the role of DWI in CD is not completely established.
Wall thickness, layered pattern of enhancement, T2 signal intensity, and ADC have been described to be sensitive to inflammation. [19] [20] [21] 23, 24, 27 In our study, a thicker bowel wall was associated with increased inflammation, with a 5.9-mm threshold on T1W post-contrast imaging, similar to what has been reported by Zappa et al. [reported threshold of approximately 6 mm]. 23 As reported in previous studies, a layered pattern at the early and parenchymal phases was associated with inflammatory activity. 12, 23, 24 The degree of wall enhancement has variable performance for inflammation. 21, 23, 24 Zappa et al. found that the degree of enhancement at the parenchymal phase [90s after contrast injection] was not associated with inflammation, in contradiction to our findings which found that a marked enhancement at 60s is associated with inflammation. 23 The discrepancy may be by various acquisition times and evaluation methods of the degree of enhancement. Our study showed that diffusion was restricted [lower ADC] in bowel segments with inflammation in the context of CD, confirming previous studies in CD. [17] [18] [19] [33] [34] [35] 33 Finally, as expected, because they were defined in order to identify the inflammation, higher Clermont and MaRIA scores were associated with inflammation. 19, 27 This is related to the fact that these scores include wall thickness, enhancement ratio, and presence of ulcers and oedema, which are all markers of inflammation. Similarly those scores were higher in cases of oedema on pathology, which is also associated with inflammation. 36 There are conflicting data on imaging assessment of bowel wall fibrosis. Zappa et al. showed that wall thickness and hyperintensity on T2-weighted imaging [T2WI], as well as the presence of fistulous disease, are correlated with histopathological fibrosis score. 23 In our study, we did not correlate imaging findings to a semiquantitative fibrosis score, but with Sirius red staining, leading to a difficult comparison with other studies. Similarly to Rimola et al., who showed that the pattern of enhancement at 70 s was not associated with the histopathological fibrosis score, we did not find any relationship between the pattern of enhancement at the parenchymal phase and the Sirius red staining. 12 However, unlike in Rimola et al., 12 we did not evaluate the pattern of enhancement at 7 min, as a delayed post-contrast acquisition at 7 min is not part of our routine MRI protocol. Finally, contrary to Tielter et al., 24 we did not find any correlation between ADC and fibrosis. However, our pathological reference was different. Indeed, they used a qualitative score, which mixed fibrosis component and muscle hypertrophy component, whereas we correlated with quantitative Sirius red staining, which reflects only collagen deposition.
There are no published reports on the correlation between imaging and muscle hypertrophy versus fibrosis in CD. Our results suggest that wall thickness on T2w images was increased in bowel segments with prominent muscular hypertrophy, compared with those with prominent fibrosis, which is an intuitive finding, as there is considerable narrowing of the bowel lumen in these cases. The presence of fistulas was also significantly and independently associated with prominent muscle hypertrophy. We did not observe an association between homogeneous pattern of enhancement and prominent fibrosis, although the pattern of enhancement is associated with high fibrosis score in Zappa et 12, 23 Moreover, the Sirius red staining only reflected the fibrosis component, whereas the semiquantitative score used by Rimola et al. mixed fibrosis and muscular hypertrophy. Important as the detection of active inflammatory disease is, we hypothesise that the estimation of the relative composition of smooth muscle and fibrosis is also important when selecting the optimal treatment. Both result from the proliferation of mesenchymal cells [including fibroblasts, myofibroblasts, and smooth muscle cells], followed by the differentiation of myofibroblasts linking to hypertrophy of smooth muscle cells and by the accumulation of excess extracellular matrix proteins [mostly collagen I, III, and V]. 37 The composition of ileal lesions is important for treatment management. First, inflammation should be treated by medical therapy including anti-inflammatory treatment. Second, the presence of fibrosis and muscular hypertrophy can influence the treatment and surgical planning. Hypothetically, a stricture with prominent muscular hypertrophy will not likely respond to new antifibrotic agents any more than in those with excessive collagen deposition, and may be treated by surgery, whereas a stricture with prominent fibrosis may potentially benefit from new antifibrotic agents. 38, 39 Besides its retrospective design, our study has several limitations. First, the sample size was relatively small, with only 35 patients and 40 analysed bowel segments. However, we used strict inclusion criteria in order to allow a better correlation between MRI and histopathological findings. Second, the quantitative analysis was performed by only one reader. However, the reproducibility of wall thickness measurement and ADC measurement were previously shown to be high. 19, 40 In conclusion, MRI predicts the histopathological tissue composition of ileal CD, including inflammation and predominant muscular hypertrophy versus predominant fibrosis, with reasonable accuracy. These findings need to be verified in a prospective study. 
